论文部分内容阅读
目的观察百奥蚓激酶胶囊治疗视网膜中央静脉阻塞的疗效。方法将确诊为视网膜中央静脉阻塞的32例患者分为两组,各16例,治疗组给予口服百奥蚓激酶胶囊,tid,每次2粒。就视力恢复情况、眼压变化、眼底出血吸收、有无新生血管生成等眼底变化以及自觉症状有无改善进行观察。与川芎嗪治疗方法比较。结果患者眼视力均有不同程度提高。结论百奥蚓激酶胶囊和川芎嗪对视网膜中央静脉阻塞均有治疗作用,但百奥蚓激酶胶囊优于川芎嗪注射液,是治疗此病的安全而患者又乐于接受的口服药物。
Objective To observe the efficacy of Rubisco in treating central retinal vein occlusion. Methods Thirty-two patients diagnosed as central retinal vein occlusion were divided into two groups (n = 16 each). The treatment group was given oral diphenyoklocin capsule, tid, two capsules each time. Changes in visual acuity, changes in intraocular pressure, retinal hemorrhage, presence or absence of angiogenesis and other changes in the fundus and whether or not to improve symptoms were observed. Compared with the treatment of ligustrazine. Results in patients with ocular visual acuity improved to varying degrees. CONCLUSION Hundred Lumbuke Kinase Capsules and Tetramethylpyrazine have a therapeutic effect on central retinal vein occlusion. However, Hundred Lumbago Kinase Capsules are superior to Tetramethylpyrazine Injection in the safety of patients and are willing to accept oral drugs.